180 related articles for article (PubMed ID: 32538750)
1. The expression of lncRNA-MALAT1 in breast cancer patients and its influences on prognosis.
Sun Z; Liu J; Liu J
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):72-78. PubMed ID: 32538750
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
3. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.
Huang NS; Chi YY; Xue JY; Liu MY; Huang S; Mo M; Zhou SL; Wu J
Oncotarget; 2016 Jun; 7(25):37957-37965. PubMed ID: 27191888
[TBL] [Abstract][Full Text] [Related]
6. Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis.
Qiao EQ; Yang HJ; Zhang XP
J Zhejiang Univ Sci B; 2020 Jun; 21(6):495-508. PubMed ID: 32478495
[TBL] [Abstract][Full Text] [Related]
7. Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population.
Peng R; Luo C; Guo Q; Cao J; Yang Q; Dong K; Wang S; Wang K; Song C
Gene; 2018 Feb; 642():241-248. PubMed ID: 29146194
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
Pang EJ; Yang R; Fu XB; Liu YF
Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
[TBL] [Abstract][Full Text] [Related]
9. Potential role of circulating long noncoding RNA MALAT1 in predicting disease risk, severity, and patients' survival in sepsis.
Geng F; Liu W; Yu L
J Clin Lab Anal; 2019 Oct; 33(8):e22968. PubMed ID: 31301104
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis.
Liu Y; Gao S; Du Q; Zhao Q
Int J Mol Med; 2019 Jan; 43(1):547-556. PubMed ID: 30387807
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma.
Ma KX; Wang HJ; Li XR; Li T; Su G; Yang P; Wu JW
Tumour Biol; 2015 May; 36(5):3355-9. PubMed ID: 25613066
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer.
Zheng L; Zhang Y; Fu Y; Gong H; Guo J; Wu K; Jia Q; Ding X
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683807
[TBL] [Abstract][Full Text] [Related]
13. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
14. MALAT1 promotes angiogenesis of breast cancer.
Huang XJ; Xia Y; He GF; Zheng LL; Cai YP; Yin Y; Wu Q
Oncol Rep; 2018 Nov; 40(5):2683-2689. PubMed ID: 30226550
[TBL] [Abstract][Full Text] [Related]
15. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
16. The MALAT1-breast cancer interplay: insights and implications.
Tufail M
Expert Rev Mol Diagn; 2023; 23(8):665-678. PubMed ID: 37405385
[TBL] [Abstract][Full Text] [Related]
17. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway.
Li Y; Liu YD; Chen SL; Chen X; Ye DS; Zhou XY; Zhe J; Zhang J
Mol Hum Reprod; 2019 Jan; 25(1):17-29. PubMed ID: 30371869
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
20. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
Jadaliha M; Zong X; Malakar P; Ray T; Singh DK; Freier SM; Jensen T; Prasanth SG; Karni R; Ray PS; Prasanth KV
Oncotarget; 2016 Jun; 7(26):40418-40436. PubMed ID: 27250026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
